Gene-directed therapy for AMD on the horizon


Iowa City, IA-The development of gene-directed therapy for common genetic ocular diseases that will be deployable on a population scale rests on coordinated research involving a series of steps. However, judging from progress made so far, such modalities might become clinically available soon, said Edwin M. Stone, MD, PhD.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.